Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stina Ramne has a total of 306 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of Different Meal Types and Macronutrients on Circulating FGF21 and Appetite in Humans: A Systematic Review of Randomized Trials

    by Trine Spragge Ekblond, Linnea Rydell, Stina Ramne, Tue Helms Andersen, Louise Groth Grunnet, Anne Raben, Jonas Salling

    Introduction and Aim: Fibroblast growth factor 21 (FGF21) is potentially involved in macronutrient specific appetite regulation by increasing preference for protein and suppressing preference for sugar and alcohol. The aim of this systematic review was to investigate how different macronutrients, including carbohydrates and specific sugars, protein, fat, alcohol and non‐sugar sweeteners, impact circulating FGF21 in humans and how food preference or appetite is associated with circulating FGF21 in response to a dietary intervention. Methods: A systematic search was conducted in the databases MEDLINE, EMBASE and CENTRAL on 9 December 2025. Eligible for inclusion were randomized controlled dietary or meal intervention studies in healthy adults, where circulating FGF21 had been measured in response to the intervention. Results: A total of 4163 records were identified, resulting in 24 included articles. Sugar, especially fructose, but also alcohol, increased postprandial FGF21 concentrations acutely, whereas protein suppressed them. Interventions lasting ≥ 24 h showed an increase in fasting FGF21 concentrations after low protein intake. No studies on non‐sugar sweeteners were identified. Studies investigating appetite and food preferences following diet‐induced FGF21 changes were very limited and inconsistent. Conclusion: FGF21 responds to changes in macronutrient compositions in humans. Specifically, fructose and alcohol increased FGF21, while protein suppressed FGF21. Evidence linking FGF21 to appetite or food preferences or non‐sugar sweeteners was limited in humans.

  • Open Access

    Alcohol, but not acetate, induces FGF21 in humans without association with subsequent food choice

    by Stina Ramne, Lars Ove Dragsted, Valerie Dinjens, Faidon Magkos, Matthew P. Gillum, Catalina Cuparencu

  • Protein intake counteracts alcohol intake in the regulation of postprandial FGF21 secretion in humans

    by Stina Ramne, Teresa Duarte da Costa Seco, Katharina B. Kuentzel, Trisha J. Grevengoed, Jasmin P. Hjerresen, Thomas Moritz, Torben Hansen, Anne Raben, Niels Grarup

    The hepatic hormone FGF21 is regulated by dietary intake. The results of this human meal study suggest that coconsumption of protein inhibits alcohol-induced FGF21 secretion in humans, similar to how protein intake previously has been shown to inhibit sugar-induced FGF21 secretion. This indicates that dietary protein is a consistent downregulator of FGF21. We found no indication that intake of retinol influences FGF21 regulation.


  • Open Access

    Distinct genetic signals at the FGF21 locus complicate studies of FGF21's role in diet regulation using human cohort data

    by Stina Ramne, Mario García-Ureña, Matthew P. Gillum, Lars Ängquist, Torben Hansen, Jordi Merino, Niels Grarup


  • Open Access

    Diet pattern determines circulating FGF21 levels while distinct FGF21 variants influence diet pattern and FGF21 levels

    by Stina Ramne, Mario García-Ureña, Matthew P Gillum, Lars Ängquist, Torben Hansen, Jordi Merino, Niels Grarup

    Experimental and genetic studies suggest that FGF21 modulates macronutrient and alcohol preferences. However, FGF21’s regulation of human appetite remains elusive. To address this gap in translation, we investigated the relationships between plasma FGF21 levels, FGF21 genetic variation and habitual macronutrient intake in a large human population. We show that the main macronutrient-associated variant rs838133 and the FGF21 cis-pQTL rs838131, both in the FGF21 gene, are distinct genetic signals. Effect directions also suggest that the influence of FGF21 variation on macronutrient intake appear more complex than by direct mediation through plasma FGF21. Only when considering this complexity at FGF21, is plasma FGF21 estimated to reduce alcohol and increase protein and fat intake using mendelian randomization. Importantly, plasma FGF21 levels are also markedly elevated by high alcohol and low protein intake. This supports the diet-regulatory mechanism of FGF21 in humans, but highlights the need for mechanistic characterization of the FGF21 genetic region.


  • Open Access

    Are we using more sugar substitutes? Wastewater analysis reveals differences and rising trends in artificial sweetener usage in Swedish urban catchments

    by Inga Haalck, Anna Székely, Stina Ramne, Emily Sonestedt, Claudia von Brömssen, Elin Eriksson, Foon Yin Lai


  • Open Access

    Clusters of carbohydrate-rich foods and associations with type 2 diabetes incidence: a prospective cohort study

    by Kjell Olsson, Esther González-Padilla, Suzanne Janzi, Anna Stubbendorff, Yan Borné, Stina Ramne, Ulrika Ericson, Emily Sonestedt

    Background: About one in ten adults are living with diabetes worldwide. Intake of carbohydrates and carbohydrate-rich foods are often identified as modifiable risk factors for incident type 2 diabetes. However, strong correlation between food variables can make it difficult to identify true associations. The purpose of this study was to identify clusters of carbohydrate-rich foods and analyse their associations with type 2 diabetes incidence in the Malmö Diet and Cancer Study cohort in southern Sweden. Methods: Dietary intake of 26 622 participants was assessed using a validated three-part diet history method: a 7-day food diary, a 168-item food frequency questionnaire, and a 60-minute interview. K-means clustering analysis identified five clusters from 21 food variables. The Cox proportional hazard regression model was applied to calculate hazard ratios (HR) and 95% confidence intervals (CI) of the association between clusters and incident type 2 diabetes. Results: The cluster analysis resulted in five clusters; high vegetables/low added sugar, high sugar-sweetened beverages, high juice, high fruit, and high refined carbohydrates/low fruit & vegetables (reference). During mean follow-up of 18 years, 4046 type 2 diabetes cases were identified. After adjustment for potential confounding (including lifestyle, body mass index, and diet), a high fruit cluster (HR 0.86; 95% CI 0.78, 0.94) was inversely associated with type 2 diabetes compared to the reference cluster. No other significant associations were identified. Conclusions: A dietary pattern defined by a high intake of fruits was associated with a lower incidence of type 2 diabetes. The findings provide additional evidence of a potential protective effect from fruit intake in reducing type 2 diabetes risk. Future studies are needed to explore this association further.


  • Open Access

    Meal sugar-protein balance determines postprandial FGF21 response in humans

    by Stina Ramne, Lisanne Duizer, Mette S. Nielsen, Niklas Rye Jørgensen, Jens S. Svenningsen, Niels Grarup, Anders Sjödin, Anne Raben, Matthew P. Gillum

    Here we test the interactions between sugar, protein, and fat in human FGF21 regulation and demonstrate that protein, but not fat, suppresses sugar-induced FGF21 secretion. This indicates that protein outweighs the effects of sugar in the secretory regulation of FGF21, and could suggest that the nutrient-specific appetite-regulatory actions of FGF21 might prioritize ensuring sufficient protein intake over limiting sugar intake.


  • Open Access

    Comparisons of Different Carbohydrate Quality Indices for Risk of Type 2 Diabetes in the Malmö Diet and Cancer Study

    by Michaela Ramstedt, Suzanne Janzi, Kjell Olsson, Esther González-Padilla, Stina Ramne, Yan Borné, Ulrika Ericson, Emily Sonestedt

    Carbohydrate quality might be more important than quantity to reduce type 2 diabetes (T2D) risk. Various metrics of carbohydrate quality exist; however, their associations with T2D have only been studied to a limited extent. Consequently, the aim was to investigate the association between four different pre-defined carbohydrate quality indices, with various amounts of fiber (≥1 g) and free sugar (<1 or <2 g) per 10 g of carbohydrates, and T2D risk among 26,622 individuals without diabetes from the Malmö Diet and Cancer cohort. Dietary data were collected through a food diary, diet frequency questionnaire, and interview. After a mean follow-up of 18 years, 4046 cases were identified through registers. After adjusting for potential confounders, no statistically significant associations were found for any of the indices. When excluding individuals with past dietary changes and potential misreporting of energy (36% of the population), lower risk was found for the following intake ratios: 10:1:2 carbohydrate:fiber:free sugar (HR = 0.82; 95% CI = 0.70–0.97), and 10:1&1:2 carbohydrate:fiber and fiber:free sugar, respectively (HR = 0.84; 95% CI = 0.72–0.97). Our findings indicate that adherence to a diet with high amounts of fiber and moderate amounts of free sugar in relation to total carbohydrate intake may be associated with a lower risk of T2D.


  • Open Access

    Genetic Loss of Sucrase-Isomaltase Function: Mechanisms, Implications, and Future Perspectives

    by Ninna Karsbæk Senftleber, Stina Ramne, Ida Moltke, Marit Eika Jørgensen, Anders Albrechtsen, Torben Hansen, Mette K Andersen

    Genetic variants causing loss of sucrase-isomaltase (SI) function result in malabsorption of sucrose and starch components and the condition congenital sucrase-isomaltase deficiency (CSID). The identified genetic variants causing CSID are very rare in all surveyed populations around the globe, except the Arctic-specific c.273_274delAG loss-of-function (LoF) variant, which is common in the Greenlandic Inuit and other Arctic populations. In these populations, it is, therefore, possible to study people with loss of SI function in an unbiased way to elucidate the physiological function of SI, and investigate both short-term and long-term health effects of reduced small intestinal digestion of sucrose and starch. Importantly, a recent study of the LoF variant in Greenlanders reported that adult homozygous carriers have a markedly healthier metabolic profile. These findings indicate that SI inhibition could potentially improve metabolic health also in individuals not carrying the LoF variant, which is of great interest considering the massive number of individuals with obesity and type 2 diabetes worldwide. Therefore, the objectives of this review, are 1) to describe the biological role of SI, 2) to describe the metabolic impact of the Arctic SI LoF variant, 3) to reflect on potential mechanisms linking reduced SI function to metabolic health, and 4) to discuss what knowledge is necessary to properly evaluate whether SI inhibition is a potential therapeutic target for improving cardiometabolic health.